CIMB in a Jan 22 research report says: “Recent strong performances by Xinfei and Yuchai prompt us to raise our FY2009 core EPS estimate for HLA by 10%, after factoring in higher gross-margin expectations of 22% (from 21.7%).
Hong Leong Asia rated outperform
written by Editor on January 26th, 2010 |
No Comments
Font size:
